Private health institutions, OCCI discuss challenges

Muscat: Oman Chamber of Commerce and Industry (OCCI) held a meeting with owners of private health institutions on Wednesday to discuss the challenges......

Rhizen Pharmaceuticals AG Announces First Patient Dosed in a Phase 2 Study of RP7214 in Covid-19 Patients

First study of RP7214, a DHODH inhibitor, in Covid-19 patients with mild, symptomatic disease on the background of promising preclinical efficacy......

Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy

-- Organon (NYSE: OGN), a global women’s health company, is launching a Public Service Announcement (PSA) that aims to raise awareness and......

Bentley Systems Announces Finalists for the 2021 Going Digital Awards in Infrastructure

Bentley Systems, Incorporated (Nasdaq:BSY), the infrastructure engineering software company, today announced the finalists for the 2021 Going Digital......

Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches

• Boehringer Ingelheim aims to develop novel cancer therapies by leveraging Abexxa’s unique technology and breakthrough antibody-based......

 Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)

• The approval marks the first time a monoclonal antibody treatment for COVID-19...
  Continue Reading >

Pandemic far from over: WHO regional director

Muscat – The overall number of COVID-19 cases and deaths in the Eastern Mediterranean region has declined in the past few weeks but the situation......

UK removes Oman from red list

Muscat – Oman is among the eight countries which will be removed from UK's Red List from September 22, easing international travel. UK......

Takeda’s EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA)......

Gradiant Achieves Strong Growth in Cleantech Water Treatment during the Pandemic

• Gradiant demonstrated strong growth during the prolonged COVID-19 pandemic
...
Continue Reading >